BEL 20 Slips 0.08% as Tech and Healthcare Stocks Decline

Belgium's benchmark stock index, the BEL 20, ended Tuesday's session with a marginal decline, weighed down by losses in the technology and healthcare sectors.

Sector Pressures Drive Modest Decline

The BEL 20 index finished the day down 0.08%, according to market data from Investing.com. The slight downturn was primarily attributed to weakness in the Technology, Healthcare, and Consumer Goods sectors, which offset gains in other areas.

Market breadth on the Brussels Stock Exchange was negative, with 51 stocks declining compared to 41 advancers. An additional 16 stocks finished the session unchanged.

Index Movers

Among the individual components of the index, performance was mixed. Stainless steel producer Aperam SA was the session's biggest loser, while chemical distributor Azelis led the gainers.

Ad

• Top Gainers:
• Azelis Corporate Services NV (EBR:AZE): +2.92% to close at 12.35
• Umicore (EBR:UMI): +2.03% to 23.08
• Groep Brussel Lambert NV (EBR:GBLB): +1.69% to 75.30
• Biggest Decliners:
• Aperam SA (AS:APAM): -3.33% to finish at 46.52
• Melexis NV (EBR:MLXS): -1.99% to 66.50
• UCB SA (EBR:UCB): -1.62% to 206.90

Broader Market Context

In the broader markets, energy prices saw gains. October WTI crude oil futures rose 0.75% to $92.17 per barrel, while the November Brent crude contract edged up 0.33% to $97.32 per barrel.

Currency markets were relatively stable. The EUR/USD pair was nearly flat at 1.16, while the U.S. Dollar Index Futures, which measures the greenback against a basket of currencies, traded 0.30% lower at 98.85.